RT-PCR Multi-Organism Detection for Antibiotic Resistance Prediction

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current antimicrobial therapy approaches are often ineffective due to the rapid emergence of antibiotic-resistant bacteria, particularly ESBL-E and CRE, which are difficult to treat with limited antibiotic options, and existing PCR technologies struggle to provide accurate, quantitative measurements for multiple organism and resistance detection.

Innovation Solution

A method utilizing RT-PCR technology to predict and evaluate antibiotic selections by classifying resistant genes and linking them to specific antibiotic classes, incorporating clinical data to determine the most effective therapy, thereby overcoming resistance mechanisms and optimizing antimicrobial stewardship.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If RT-PCR technology is used to detect multiple organisms and resistance genes in a single sample, then diagnostic accuracy and speed are improved, but the ability to derive exact quantitative measures deteriorates

Engineering Contradiction:

Improveorganism identification accuracyVSAvoidquantitative measurement capability

Core Design Contradiction:

Measurement precisionVSLoss of information

Solution Approach 1:

The patent segments the analysis by separating qualitative detection (organism identification) from quantitative assessment (amplification curve analysis). Multiple organisms and resistance genes are detected independently through specific PCR primers, while quantitative information is derived separately through curve analysis, allowing both functions to coexist without interference

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent transitions from traditional binary PCR results (positive/negative) to a dimensional approach by analyzing amplification curves. This adds a quantitative dimension to the diagnostic process, where the shape, slope, and threshold cycles of amplification curves provide additional information about organism load and characteristics beyond simple presence/absence

Inventive Principle:

Principle #17Another dimension (Dimensionality change)

2Reliability

If multiple antibiotics are prescribed empirically to cover all possible resistant bacteria, then treatment coverage is improved, but antibiotic misuse and resistance development worsen

Engineering Contradiction:

Improvetreatment coverageVSAvoidantibiotic resistance development

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent performs preliminary identification of specific organisms and their resistance genes through RT-PCR before initiating antibiotic therapy. This advance knowledge allows clinicians to select targeted antibiotics rather than using broad-spectrum empiric therapy, preventing the development of resistance while ensuring appropriate treatment coverage from the start

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The system provides feedback by identifying specific resistance genes (such as ESBL genes, carbapenemase genes) present in the patient's infection, allowing clinicians to adjust antibiotic selection based on this molecular feedback rather than relying on traditional culture-based susceptibility testing, thereby optimizing therapy while minimizing resistance development

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for targeted antibiotic selection specific to each patient, reducing the likelihood of ineffective treatments and promoting the use of oral therapy before IV, thus addressing the antibiotic resistance crisis and improving patient outcomes.

Implementation Method 1

A polymerase chain reaction (PCR) test is a diagnostic that can rapidly determine infection by analyzing a sample to see if it contains genetic material for presence of bacteria, viruses, fungus, or parasites

Methodology Applied

Scientific EffectPolymerase chain reaction (PCR):

Implementation Method 2

There are many different nucleic acid test technologies available, such as Real-Time PCR technology, a Qualitative test. Qualitative tests are well suited for the detection of microorganisms in specimens whose presence, at any level, is associated with a disease state. This process may be known as reverse transcription (RT)

Methodology Applied

Scientific EffectReverse transcription (RT):

Data Source

PatentUS20230340616A1Method for predicting and evaluating antimicrobial therapy when molecular PCR diagnostic testing results yield multi-organisms and multi-resistant bacteria from a single DNA sample

Publication Date: 2023.10.26 ADVANCED THERAPEUTIC ASSIST

AI summary

A method for predicting and evaluating antimicrobial therapy for patient specific molecular results when molecular testing yields multi-organism and multi-resistant bacterial. Essential in the fight against antimicrobial resistance is the effective use of antibiotics. An exemplary method provides healthcare providers a therapeutic guide for optimizing patient outcomes by significantly improving antibiotic stewardship by using resistant gene enzymes to guide antibiotic therapy most likely to succeed.